Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Xiaohong Pu"'
Autor:
Xiang Dong, Hongqian Guo, Changwei Ji, Xiaohong Pu, Yiqi Zhu, Xiaozhi Zhao, Weidong Gan, Dongmei Li
Publikováno v:
Cancer Management and Research
Yiqi Zhu,1,* Xiaohong Pu,2,* Xiang Dong,3 Changwei Ji,1 Hongqian Guo,1 Dongmei Li,4,5 Xiaozhi Zhao,1 Weidong Gan1 1Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, Peo
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
To gain insight into the clinicopathologic profile of colorectal carcinomas harboring oncogenic NTRK fusions based on eastern populations as well as make the best testing algorithm for the screen, we use pan-Trk immunohistochemistry (IHC), fluorescen
Autor:
Jing Cai, Jun Chen, Qing Ye, Yudong Qiu, Hongyan Wu, Yao Fu, Xiangshan Fan, Xin Yang, Shen Yue, Xiaohong Pu
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 12, Iss 3, Pp 1-14 (2021)
Cell Death and Disease, Vol 12, Iss 3, Pp 1-14 (2021)
Chromosomal translocations involving fibroblast growth factor receptor 2 (FGFR2) gene at the breakpoints are common genetic lesions in intrahepatic cholangiocarcinoma (ICC) and the resultant fusion protein products have emerged as promising druggable
Autor:
Xi-Wei Ding, Xiaohong Pu, Liang Mao, Jun Yang, Yudong Qiu, Qing Ye, Hongyan Wu, Jiong Shi, Qin Huang, Xiangshan Fan, Jun Chen
Publikováno v:
Human Pathology. 76:100-109
Intrahepatic cholangiocarcinoma (ICC) is a subtype of primary liver cancer rarely curable by surgery that is increasing rapidly in incidence. Chromosomal translocations and amplifications of the fibroblast growth factor receptor 2 (FGFR2) locus are p